About A-Bio Pharma
A-Bio Pharma is a company based in Singapore (Singapore) founded in 2002 was acquired by Luye Pharma in July 2010. A-Bio Pharma offers products and services including Owner's Project Management, Process Engineering, Operational and Technical Services, and Facilities Services. A-Bio Pharma operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name A-Bio Pharma Pte. Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Luye Pharma
(Jul 31, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of A-Bio Pharma
A-Bio Pharma offers a comprehensive portfolio of products and services, including Owner's Project Management, Process Engineering, Operational and Technical Services, and Facilities Services.
Manages biopharma capital projects from concept to readiness.
Designs and optimizes biopharma processes for efficient operations.
Provides risk assessments and compliance support for facilities.
Handles facility life cycle planning and maintenance programs.
Funding Insights of A-Bio Pharma
Detailed funding history for A-Bio Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in A-Bio Pharma
A-Bio Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Luye Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Innovative pharmaceutical products and treatments are developed and commercialized.
|
Locked | Locked | Locked |
Investor details for A-Bio Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by A-Bio Pharma
Investment portfolio details for A-Bio Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - A-Bio Pharma
Detailed financials for A-Bio Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
A-Bio Pharma Comparisons
Peer comparison for A-Bio Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of A-Bio Pharma
A-Bio Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of A-Bio Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on A-Bio Pharma
Complete news archive for A-Bio Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about A-Bio Pharma
A-Bio Pharma was founded in 2002.
A-Bio Pharma is headquartered in Singapore, Singapore.
A-Bio Pharma was founded in 2002 in Singapore. Mammalian cell-line development services are offered within the biopharmaceutical sector. Operations focus on process development and scale-up activities, including ART-123, a recombinant protein targeted at disseminated intravascular coagulation in sepsis cases. Services support recombinant protein production, with activities based in Singapore.
A-Bio Pharma's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
A-Bio Pharma offers Owner's Project Management, Process Engineering, Operational and Technical Services, and Facilities Services.
A-Bio Pharma has 1 investor. Key investors include Luye Pharma.